- Preview Available
- Scholarly Journal
519 A first-in-human, multicenter, phase 1/2, open-label study of XTX101 in patients with advanced solid tumors
Powderly, John; Teleen Norman; Duncan, Meghan; Huber, Martin; Jennifer O’Neil
; et al.
Journal for Immunotherapy of Cancer; London Vol. 9, Iss. Suppl 2, (Nov 2021): A549-A549.
DOI:10.1136/jitc-2021-SITC2021.519
We're sorry, there is no preview available.
Try and log in through your library or institution to see if they have access.
